The Valley Desk

NCT06007690 · Interventional trial

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

Overall registry status Active not recruiting

Phase 3

Conditions Choroidal Melanoma, Indeterminate Lesions, Ocular Melanoma, Uveal Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov